Skip to main content
Equibles

Phillip G. Febbo

Veracyte, Inc. (VCYT)

Equibles does not estimate personal net worth.

Get an email with a short summary when Veracyte, Inc. publishes a filing, an earnings call transcript or a press release.

Get VCYT alerts

About Phillip G. Febbo

The proxy statement of Veracyte, Inc. reports total compensation of $2,500,972 for Phillip G. Febbo in fiscal 2025, including a base salary of $561,000. Disclosed compensation is on record for 3 fiscal years. Phillip G. Febbo has spoken on 1 earnings call across 1 company, most recently for Veracyte, Inc. on February 25, 2026. Veracyte, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Veracyte, Inc. includes Marc Stapley (CEO and Board Member), Bonnie H. Anderson (Chairman), Rebecca Chambers (CFO) and 7 others.

Phillip G. Febbo on recent calls

“So I would say the GU-ASCO abstracts and aggregate really demonstrate how understanding the different subtypes of earlier stage bladder cancer is increasingly becoming part of care because bladder cancer is in this transition where we're really looking at how to maximize response to new adjuvant therapy to move…”
Other, Veracyte, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Veracyte, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Veracyte, Inc. (VCYT) $561,000 $2,500,972
2024 Veracyte, Inc. (VCYT) $550,000 $2,789,661
2023 Veracyte, Inc. (VCYT) $137,500 $3,787,041

Recent activity